For research use only. Not for therapeutic Use.
PKUMDL-WQ-2201(Cat No.:I034865)is a small molecule compound developed for its potential use in the treatment of various diseases, including cancer. It is designed to target specific enzymes, receptors, or cellular pathways involved in disease progression. PKUMDL-WQ-2201 has shown promise in preclinical studies for its ability to modulate critical biological processes, such as cell cycle regulation, apoptosis, and tumor growth. Ongoing research is focused on evaluating its effectiveness and safety in clinical trials, with the goal of developing it as a therapeutic option for conditions like cancer and other disorders related to dysregulated cellular functions.
Catalog Number | I034865 |
CAS Number | 592474-91-4 |
Synonyms | 2-chloro-4-[5-[(E)-(ethylcarbamothioylhydrazinylidene)methyl]furan-2-yl]benzoic acid |
Molecular Formula | C15H14ClN3O3S |
Purity | ≥95% |
IUPAC Name | 2-chloro-4-[5-[(E)-(ethylcarbamothioylhydrazinylidene)methyl]furan-2-yl]benzoic acid |
InChI | InChI=1S/C15H14ClN3O3S/c1-2-17-15(23)19-18-8-10-4-6-13(22-10)9-3-5-11(14(20)21)12(16)7-9/h3-8H,2H2,1H3,(H,20,21)(H2,17,19,23)/b18-8+ |
InChIKey | XPACBFAEZIPDRT-QGMBQPNBSA-N |
SMILES | CCNC(=S)N/N=C/C1=CC=C(O1)C2=CC(=C(C=C2)C(=O)O)Cl |